Paragard IUD Lawsuit Update October 2026: 4,224 Cases Pending, the April 2027 Trial & What Comes Next

As of October 1, 2026, 4,224 Paragard IUD lawsuits are pending in federal multidistrict litigation (MDL No. 2974) in the Northern District of Georgia. The first bellwether trial ended in a defense verdict in February 2026; the next trial, Robere v. Teva, is scheduled for April 12, 2027. No global settlement has been announced.

Key facts

  • 4,224 cases pending in MDL No. 2974 as of October 1, 2026 (JPML); 4,552 cases filed in total.
  • The first bellwether trial ended February 5, 2026, with the jury ruling for Teva.
  • The second bellwether trial, Robere v. Teva, was moved to April 12, 2027.
  • The 11th Circuit Court of Appeals will weigh in on a key preemption question; the litigation is expected to pause after the next trial while the appeal is resolved.
  • Claims are split by ownership era: Teva sold Paragard to CooperSurgical in a $1.1 billion deal that closed November 1, 2017.

Watch our Problem Solved channel for plain-English explainers on complex legal and money topics: https://www.youtube.com/@problemsolved-x3m.

What the Paragard IUD Is

Paragard is a copper intrauterine device (an IUD is a small, T-shaped contraceptive placed inside the uterus to prevent pregnancy for years without daily action). Unlike hormonal IUDs, Paragard uses a copper-wrapped plastic frame — sold as the Paragard T 380, T 380A, and TCu380A — to prevent fertilization. Because it contains no hormones, it became a popular choice for women who could not or did not want hormonal birth control, and it was implanted in a very large number of women.

What the Lawsuits Allege

Plaintiffs allege that the Paragard IUD can fracture — crack or break apart — during routine removal, leaving fragments inside the uterus. Those retained pieces, they say, have caused internal injuries, pain, infections, scarring, and in some cases the need for additional procedures, from hysteroscopy (a surgical look inside the uterus) to hysterectomy (surgical removal of the uterus). The core legal theories are design defect (the device was unreasonably prone to breaking) and failure to warn (doctors and patients were not adequately told about the breakage risk). The defendants — originally Teva Pharmaceuticals and later CooperSurgical — deny the device is defective.

The Numbers: Where the Litigation Stands

Paragard cases from across the country were centralized as MDL No. 2974 in the U.S. District Court for the Northern District of Georgia, before Judge Leigh Martin May. The JPML (the federal body that consolidates similar federal cases before one judge) reported 4,224 actions pending as of October 1, 2026, out of 4,552 filed since the litigation began — one of the larger active product-liability MDLs. Filings have slowed but have not stopped.

The Bellwether Trials So Far

A bellwether trial is a test case — a handful of representative cases tried first so both sides can see how juries respond to the evidence, which usually sets the terms for settlement negotiations. The first Paragard bellwether went to trial in early 2026, and on February 5 the jury rejected both the design-defect and failure-to-warn theories and ruled for Teva. A single defense verdict shifts momentum, because the defense can argue that juries may not accept the claims — but one verdict is not dispositive, and mass tort history is full of first-round defense wins followed by plaintiff victories that reset the entire negotiation.

What Happens Next: Robere v. Teva and the Appeal

The second federal bellwether, Robere v. Teva, had been scheduled for September 28, 2026, but a September 16, 2026 scheduling order moved it to April 12, 2027, with motions in limine (pretrial requests about what evidence the jury may hear) due October 22, 2026 and the final pretrial conference set for March 29, 2027. Four more cases — White, Gutierrez, Rodriguez, and Rounds — were identified in September 2026 for the next bellwether wave. Meanwhile, in April 2026 the 11th Circuit granted Teva's request for an interlocutory appeal (an early appeal of a ruling, taken before the case finishes) on whether federal law preempts (overrides) the state-law warning claims. The litigation is expected to be largely stayed after the next trial while the appeal is decided — and if the 11th Circuit sides with Teva, many warning claims could be in jeopardy.

Teva or CooperSurgical: Who Is Responsible?

On September 11, 2017, Teva announced it would sell Paragard to CooperSurgical in a $1.1 billion all-cash deal; the sale closed on November 1, 2017. Devices implanted before that date fall into the Teva era, later ones into the CooperSurgical era, and the two companies dispute who answers for which claims. Both are defendants in the MDL. Product identification — proving which company owned the brand when the device was implanted — is one of the first things a lawyer investigates.

Can You Still File? Eligibility and Deadlines

Lawyers are still accepting Paragard cases, and new complaints continue to be filed into the MDL. The typical claim involves an IUD that broke during removal with fragments retained, requiring follow-up care, imaging, surgery, or treatment for related injuries. The deadline to file — the statute of limitations — is set by each state, often between one and four years from when the injury was discovered, so a late filing can be barred even when the injury is real. Gather your medical records (the implantation and removal reports matter most), confirm which Paragard model you had, and speak promptly with a lawyer who handles mass tort product cases. For context on choosing counsel, see our guide to Paragard lawyers in 2026.

How a Mass Tort Case Like This Works

A multidistrict litigation is not a class action: each woman keeps her own case and her own lawyer, but pretrial proceedings are coordinated before one judge. Most mass tort firms work on contingency (paid from any recovery, not upfront), so a case review usually costs nothing. If a global settlement is eventually reached, claims are typically sorted into tiers by injury severity. There is no guarantee of any payment — compensation varies widely by case, and most settlements are confidential. Similar device litigation, including Mirena IUD lawsuits and Essure birth control lawsuits, has followed the same arc.

Who Benefits From This — and Who Does Not

Who benefits most from this guide:

Women whose Paragard IUD fractured during removal, leaving fragments inside the body How: that breakage-on-removal pattern is the core allegation, and the typical claim involves follow-up care, imaging, surgery, or treatment for related injuries

Women who can document their implantation and removal reports and identify which Paragard model they had How: product identification comes first: devices implanted before November 1, 2017 fall into the Teva era and later ones into the CooperSurgical era, and the two companies dispute who answers for which claims

Women still inside their state's filing window How: new complaints continue to be filed into MDL No. 2974, which had 4,224 actions pending out of 4,552 filed as of October 1, 2026, while state deadlines often run one to four years from when the injury was discovered

Who does not benefit:

Anyone expecting a settlement payout now How: no global settlement has been announced as of October 2026, both sides are waiting for more trial results, and the first bellwether on February 5, 2026 ended in a defense verdict for Teva

Anyone whose device was removed intact with no injury How: the claims described here allege fracture with retained fragments and resulting injury, not the mere use of the device

Anyone who files after their state's deadline has passed How: a late filing can be barred even when the injury is real

For the device-by-device comparison behind these cases, see our Mirena IUD lawsuit guide.

Frequently Asked Questions

How many Paragard lawsuits are there as of October 2026?

4,224 cases are pending in MDL No. 2974, and 4,552 have been filed in total, according to the October 1, 2026 JPML report.

Has there been a Paragard settlement?

No global settlement has been announced as of October 2026. Both sides are waiting for more trial results before serious settlement negotiations can begin.

When is the next Paragard trial?

The next federal bellwether, Robere v. Teva, is scheduled to begin April 12, 2027, after being moved from September 2026.

What injuries qualify for a Paragard lawsuit?

Claims generally involve a Paragard IUD that fractured during removal, leaving fragments inside the body and causing injuries such as pain, infection, scarring, or the need for surgery.

Is it too late to file a Paragard lawsuit?

Not necessarily — new cases are still being filed. The deadline depends on your state's statute of limitations, so speaking with an attorney promptly is the safest move.

Who benefits from a Paragard claim, who does not, and how do I start?

Women whose Paragard IUD fractured during removal with fragments retained benefit most, especially when implantation and removal reports identify the model and the filing is still inside the state's deadline, since new complaints continue to be filed into MDL No. 2974. People expecting a settlement payout now do not benefit, because no global settlement has been announced as of October 2026, and neither do people whose device came out intact with no injury. Start by gathering your implantation and removal reports, confirming which Paragard model you had, and speaking promptly with a lawyer who handles mass tort product cases, since state deadlines often run one to four years from discovery.

This article is general information about litigation, not legal advice. For guidance about your own situation, consult a licensed attorney.

Watch on YouTube

Problem Solved on YouTube